Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge
Crossref DOI link: https://doi.org/10.1007/s11060-016-2196-8
Published Online: 2016-07-11
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
N. Cagney, Daniel
Alexander, Brian M.
Hodi, F. Stephen
Buchbinder, Elizabeth I.
Ott, Patrick A.
Aizer, Ayal A.
License valid from 2016-07-11